PPARG and Hepatic fibrosis: We used a synthesis method modified from a previous design of dendrimer–graphene nanostars (DGNS) [7] to obtain DGNS linked to a low dose of the GW1929 PPARγ agonist (DGNS-GW) to induce macrophage M2 polarization for the treatment of liver fibrosis.